Biosimilars 2020 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
2020 also marked the ten-year anniversary of the enactment of the Biologics Price Competition and Innovation Act (BPCIA), which created the abbreviated licensure pathway for biosimilar products to attain FDA approval. Introduction. The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs.
52 
Let's personalize your content